Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159526 | 5825001 | F | 2 | 5159526-8 | 19961201 | 20061106 | 20061120 | EXP | FR-2005-005873 | BERLEX INC. | 39 | YR | F | N | 64 | KG | 20061117 | PH | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159526 | 1007888287 | PS | BETAFERON (INTERFERON BETA - 1B) | 2 | SUBCUTANEOUS | 8 MIU/ML, EVERY 2D, SUBCUTANEOUS; 250 UG, EVERY 2D, SUBCUTANEOUS | Y | N | |||
| 5159526 | 1007918835 | SS | IMOVANE (ZOPICLONE) | 2 | ORAL | 1 TA(S), BED T., ORAL | U | U | |||
| 5159526 | 1007918836 | C | DOLIPRANE | 2 | |||||||
| 5159526 | 1007918837 | C | RANITIDINE HYDROCHLORIDE | 1 | |||||||
| 5159526 | 1007918838 | C | MAALOX (MAGNESIUM HYDROXIDE, ALGELDRATE) | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5159526 | 1007888287 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5159526 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 5159526 | COUGH |
| 5159526 | DEREALISATION |
| 5159526 | HALLUCINATION |
| 5159526 | INFLUENZA LIKE ILLNESS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5159526 | FGN |
| 5159526 | HP |
| 5159526 | LIT |
| 5159526 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5159526 | 1007888287 | 19960501 | 19971201 | ||
| 5159526 | 1007888287 | 20020201 | 20030101 |